Skip to content

Homeopathic treatment of stoppage of menses

Efficacy of individualized homoeopathic medicines in the symptomatic improvement of menopausal syndrome: A double-blind, randomized, placebo-controlled trial - Nil

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064643
Enrollment
93
Registered
2024-03-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N951- Menopausal and female climactericstates

Interventions

dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within

Sponsors

D. N. De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from Menopausal syndrome (ICD-11-GA30.0) presenting with symptoms (hot flashes, mood changes, vaginal dryness, sleep disturbances, etc.) of not less than 3 months of duration 2. Age between 40 and 55 years 3. Mild to moderate menopausal symptoms - MRS score mild 5-8, moderate 9-16 4. Participants having prior experience or knowledge of the treatment; e.g., primed to expect ‘homoeopathic aggravation’ and available treatment options for the disease conditions, intimated through Patient Information Sheet

Exclusion criteria

Exclusion criteria: 1. Not willing to give informed consent or to comply with the study procedure. 2. Hysterectomy done and/or receiving any kind of hormone therapy. 3. Any life-threatening diseases or recently active physical disease. 4. In some condition when requiring emergency or surgical intervention. 5. Presence of uncontrolled medical conditions such as diabetes, hypertension, cardiac disorder & thyroid disorder. 6. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life. 7. Undergoing homoeopathic treatment for any chronic disease within last six months. 8. Simultaneous participation in any other clinical trial. 9. Vulnerable population - Unconscious, non-ambulatory, too sick for consultation, differently abled, terminally ill or critically ill patients, mentally incompetent people. 10. Self-reported immune-compromised state. 11. Tobacco chewing and/or smoking, alcoholism and/or any other form(s) of substance abuse and/or dependence

Design outcomes

Primary

MeasureTime frame
Menopause Rating Scale (MRS)Timepoint: Baseline, every month, up to 4 months

Secondary

MeasureTime frame
Measure Yourself Medical Outcome Profile version 2 (MYMOP-2)Timepoint: Baseline, every month, up to 4 months;Menopause specific quality of life questionnaire (MENQOL)Timepoint: Baseline, every month, up to 4 months

Countries

India

Contacts

Public ContactSangita Saha

D. N. De Homoeopathic Medical College and Hospital

dr.sangita78@gmail.com9433849505

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026